Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Workshop: towards new treatments for tuberculosis 18 November 2016NewsCorporate Regulatory information – New guidance on type II variations and marketing authorisation extensions for orphan-designated medicines 18 November 2016NewsCorporate EMA website briefly unavailable on 18 November 17 November 2016News Webinar: How can clinical research networks support developers of medicines for children? 16 November 2016NewsCorporatePaediatrics The European Commission launches a public consultation on the Paediatric Regulation 15 November 2016NewsPaediatrics Revising the guideline on first-in-human clinical trials 15 November 2016Press releaseCorporateRegulatory and procedural guidance Modelling and simulation in the development of medicines 14 November 2016NewsCorporate Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of 8-10 November 2016 11 November 2016Press releaseVeterinary Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 7-10 November 2016 11 November 2016NewsHuman How to facilitate development of cancer treatment based on genetically modified T-cells 8 November 2016NewsCorporate 1 … 145 146 147 148 149 Page 149 of 380 150 151 152 153 … 380
Regulatory information – New guidance on type II variations and marketing authorisation extensions for orphan-designated medicines 18 November 2016NewsCorporate
Webinar: How can clinical research networks support developers of medicines for children? 16 November 2016NewsCorporatePaediatrics
The European Commission launches a public consultation on the Paediatric Regulation 15 November 2016NewsPaediatrics
Revising the guideline on first-in-human clinical trials 15 November 2016Press releaseCorporateRegulatory and procedural guidance
Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of 8-10 November 2016 11 November 2016Press releaseVeterinary
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 7-10 November 2016 11 November 2016NewsHuman
How to facilitate development of cancer treatment based on genetically modified T-cells 8 November 2016NewsCorporate